Some people slow down in summer, but here at The Children's Hospital of Philadelphia, hot weather is no impediment to making research advances. This week, our roundup of CHOP research in the news covers a broad range of them.
Improving exclusive human milk feedings for NICU infants is a major public health issue in India, where Diane Spatz, PhD, RN-BC, FAAN, director of The Children’s Hospital of Philadelphia’s Breastfeeding and Lactation Program, spent two weeks teaching nurses and physicians about human milk and implementation of her 10 Step Model for Human Milk and Breastfeeding in Vulnerable Hospitals.
CAR T-cell therapy tops this week's research roundup, with news about the experimental immunotherapy designed to re-engineer a patient's cells to fight cancer making late-breaking and captivating headlines across the nation.
Stephen Hunger, MD and a team of researchers used highly sensitive deep sequencing techniques to see how genetic changes in acute lymphoblastic leukemia cells evolve from diagnosis to remission and relapse.
Researchers from the Children's Oncology Group (COG) have developed a new standardized dosing method for anticancer drugs in infants to use across all COG clinical trials. This unified method, based on dose banding and organized into tables for different drugs and dose levels, will address the limitations and variability that researchers can encounter in current methods.
An international collaboration of researchers has identified several progressive series of mutations that occur in tumor cells responsible for aggressive subsets of neuroblastoma that relapse after chemotherapy.
Pediatric oncology researchers at The Children’s Hospital of Philadelphia are driven to find new treatments for childhood cancer, and the Hyundai Hope On Wheels program is supporting their hard work by awarding a 2014 Scholar Hope grant to help fund investigations that focus on the aggressive form of neuroblastoma.
September marks National Childhood Cancer Awareness Month, and this year at Children's Hospital of Philadelphia, we kick-started the commemorative period on the heels of exciting news about breakthroughs in pediatric cancer immunotherapy research.